Survival in a real-world cohort of patients with mixed phenotype transthyretin amyloidosis treated with tafamidis: an analysis from the Transthyretin Amyloidosis Outcomes Survey PC107 (#10)
Year: 2024
Type: other
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4396810804
